Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Dr Reddys Laboratories (RDY) over the last 5 years, with Q3 2025 value amounting to -$3.2 million.

  • Dr Reddys Laboratories' Change in Accured Expenses rose 7198.73% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.9 million, marking a year-over-year decrease of 7036.15%. This contributed to the annual value of -$86.3 million for FY2025, which is 35001.55% down from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Change in Accured Expenses of -$3.2 million as of Q3 2025, which was up 7198.73% from -$40.2 million recorded in Q2 2025.
  • In the past 5 years, Dr Reddys Laboratories' Change in Accured Expenses ranged from a high of -$3.2 million in Q3 2025 and a low of -$102.0 million during Q2 2024